DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPSAll faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.

The faculty, CCO staff, and NCCN staff reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity.

Faculty:Andrew Armstrong, MD, ScM, FACP, has disclosed that he has received consulting fees from Astellas/Medivation, Bayer, Dendreon, Eisai, and Janssen and funds for research support from Active Biotech/Ipsen, Astellas/Medivation, Bayer, Dendreon, Gilead, Janssen, Novartis, Pfizer, and sanofi-aventis.

Alan H. Bryce, MD, has no real or apparent conflicts of interest to report.

Tanya B. Dorff, MD, has disclosed that she has received consulting fees from Astellas, Bayer, Dendreon, Genentech, and Pfizer.

The NCCN clinical information team listed below, who has reviewed content, has no relevant financial relationships to disclose:Deborah Freedman-Cass, PhD

The ACCME/ANCC/ACPE defines “conflict of interest” as when an individual has an opportunity to affect CE content about products or services of a commercial interest with which he/she has a financial relationship.

ACCME, ACPE, and ANCC focuses on financial relationships with commercial interests in the 12-month period preceding the time that the individual is being asked to assume a role controlling content of the CE activity. ACCME, ACPE, and ANCC have not set a minimal dollar amount for relationships to be significant. Inherent in any amount is the incentive to maintain or increase the value of the relationship. The ACCME, ACPE, and ANCC defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that create a conflict of interest.

All faculty for this CE activity are competent in the subject matter and qualified by experience, training, and/or preparation to the tasks and methods of delivery.

DISCLOSURE OF UNLABELED USEThis educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. NCCN and Clinical Care Options, LLC do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of NCCN and Clinical Care Options, LLC. Please refer to the official prescribing information for each product for discussion of approved indication, contraindications, and warnings.

PhysiciansThis activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of National Comprehensive Cancer Network and Clinical Care Options, LLC. The NCCN is accredited by the ACCME to provide continuing medical education for physicians.

The National Comprehensive Cancer Network designates this enduring activity for a maximum of 1.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

NursesThe National Comprehensive Cancer Network (NCCN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation. NCCN designates this educational activity for a maximum of 1.81 contact hours. Accreditation as a provider refers to the recognition of educational activities only; accredited status does not imply endorsement by NCCN or ANCC of any commercial products discussed/displayed in conjunction with the educational activity.